Hims & Hers gummy prescription hit 88% daily adherence by solving the pill problem

Hims & Hers launched its first prescription gummy and reported an 88% daily adherence rate, according to Modern Retail. That number matters because the industry standard for oral prescription adherence hovers around 50%, meaning half of patients don't take their medication as directed. The gummy format didn't just improve compliance — it eliminated the friction that causes patients to skip doses.

The company reformulated a prescription medication into a gummy form factor, something consumers already associate with daily vitamins and supplements. Instead of requiring water, a precise swallowing motion, or timing around meals, the gummy fits into the morning routine patients already have. It tastes neutral to pleasant, requires no preparation, and can be taken anywhere. The physical product became easier to use than the behavior it replaced.

This worked because Hims & Hers identified the gap between intent and action. Patients want to take their medication. They fail because the format demands a behavior change: remembering to carry pills, finding water, dealing with nausea or swallowing difficulty. The gummy removed those barriers by matching an existing habit loop. Consumers already take gummy vitamins in the morning. Dropping a prescription into that same routine required no new behavior, just a swap. The 88% adherence rate reflects that elimination of friction, not better patient education or reminders.

The broader mechanism is format arbitrage. A product that solves the same problem in a form factor borrowed from a category with higher engagement inherits that engagement. Gummies have high daily adherence in the supplement category because they're easy and taste acceptable. Hims & Hers moved a prescription into that format and captured the same adherence rate. The active ingredient stayed the same. The delivery system changed, and behavior followed.

A small physical-product brand can run this play without FDA approval or pharmaceutical licensing. Identify the product you sell that requires repetition but has low follow-through. Look at adjacent categories where consumers already perform that repetition successfully, then borrow the format. If you sell a skincare product with poor daily compliance, look at how deodorant or toothpaste achieves near-universal daily use. If you sell a supplement customers forget to take, study the formats that sit on bathroom counters and get used every morning.

The execution is simple. Take your lowest-engagement SKU and list the friction points: requires water, needs refrigeration, hard to open, unclear dosage, boring routine. Then audit the high-engagement products in your customer's home. What do they use every single day without thinking? Match your product to that form factor. A powder becomes a stick pack that fits in a coffee mug. A capsule becomes a chewable. A cream becomes a wipe. The cost is reformulation and new packaging. The return is the adherence rate of the category you borrowed from.

Test it narrow. Run a 500-unit batch with your existing customers who have the worst repeat purchase rate. Message it as solving the specific friction they complain about: no water needed, no swallowing, no mess. Track repurchase over 60 days. If your repeat rate moves from 40% to 70%, you found a format with built-in behavior change. Scale it as your hero SKU and retire the version no one finishes.

The pattern here extends past gummies. Any time your product requires a behavior your customer doesn't already have, borrow the format from a category where that behavior is automatic. You're not competing on efficacy or ingredient story. You're competing on whether the product gets used at all.